ArticleInternational journal of general medicine2026
Development and Validation of a Nomogram for Predicting Poor Outcome in Spontaneous Cervical Artery Dissection.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and validation of a prognostic nomogram for predicting the progression risk of HCC after lenvatinib therapy.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This exploratory study aimed to develop a preliminary nomogram for risk assessment of poor prognosis in spontaneous cervical artery dissection (sCAD) and evaluate its statistical performance using internal validation. Methods: We retrospectively analyzed 75 patients with sCAD (mean age 51.8 ± 14.0 years; 41 males [55%] and 34 females [45%]) diagnosed between November 2013 and April 2024. Poor prognosis was defined as imaging-confirmed acute cerebral infarction or hemorrhage (n=38); the remaining 37 patients comprised the good prognosis group. Due to the small sample size, variables with p<0.2 in univariate analysis (sex, extracranial CAD type, hypertension, hyperhomocysteinemia) were considered for multivariate modeling, though none were statistically significant predictors (all p>0.05). A multivariate logistic regression-based nomogram was constructed and internally validated using 1000 bootstrap resamples. Results: The final model included the four variables above. Only non-intramural hematoma (other) CAD type showed statistical significance in the multivariate model (OR=13.41, 95% CI: 2.89-62.17, P<0.01), while sex, hypertension, and hyperhomocysteinemia did not, likely reflecting statistical instability from inadequate power. In bootstrap internal validation, the model demonstrated moderate discrimination (AUC=0.788, 95% CI: 0.686-0.891) with a Brier score of 0.185. Hosmer-Lemeshow test indicated acceptable calibration (χ Conclusion: This pilot study generates the hypothesis that ultrasonographic CAD type, combined with clinical variables, may aid in predicting sCAD outcomes. However, due to the small sample size (9.5 events/variable), lack of external validation, and inclusion of non-significant predictors, this model is not ready for clinical application. Multi-center prospective validation in a cohort of at least 400 patients is required before any clinical utility can be claimed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.